2,449,364 Shares in Sotera Health (NASDAQ:SHC) Acquired by Darsana Capital Partners LP

Darsana Capital Partners LP bought a new stake in shares of Sotera Health (NASDAQ:SHC - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 2,449,364 shares of the company's stock, valued at approximately $29,074,000. Sotera Health comprises 0.8% of Darsana Capital Partners LP's investment portfolio, making the stock its 13th largest holding. Darsana Capital Partners LP owned approximately 0.87% of Sotera Health at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. CWM LLC lifted its holdings in shares of Sotera Health by 86.1% during the 2nd quarter. CWM LLC now owns 2,146 shares of the company's stock valued at $25,000 after buying an additional 993 shares during the period. Swiss National Bank lifted its holdings in shares of Sotera Health by 0.5% during the 1st quarter. Swiss National Bank now owns 195,900 shares of the company's stock valued at $2,353,000 after buying an additional 1,000 shares during the period. TD Asset Management Inc lifted its holdings in shares of Sotera Health by 1.5% during the 2nd quarter. TD Asset Management Inc now owns 123,454 shares of the company's stock valued at $1,465,000 after buying an additional 1,800 shares during the period. Securian Asset Management Inc. lifted its holdings in shares of Sotera Health by 23.0% during the 1st quarter. Securian Asset Management Inc. now owns 10,178 shares of the company's stock valued at $122,000 after buying an additional 1,900 shares during the period. Finally, State of Alaska Department of Revenue lifted its holdings in shares of Sotera Health by 20.6% during the 1st quarter. State of Alaska Department of Revenue now owns 13,490 shares of the company's stock valued at $162,000 after buying an additional 2,300 shares during the period. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

SHC has been the topic of several research analyst reports. Royal Bank of Canada reissued an "outperform" rating and set a $17.00 price target on shares of Sotera Health in a report on Tuesday, August 6th. Barclays raised their target price on Sotera Health from $14.00 to $17.00 and gave the stock an "overweight" rating in a report on Tuesday, August 6th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $15.70.

Insiders Place Their Bets

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm's stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the completion of the transaction, the director now owns 49,215,301 shares in the company, valued at $739,705,974.03. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 55.12% of the stock is currently owned by company insiders.

Sotera Health Price Performance

SHC stock remained flat at $16.59 during trading on Thursday. The company's stock had a trading volume of 1,366,804 shares, compared to its average volume of 1,364,021. Sotera Health has a 1-year low of $10.71 and a 1-year high of $17.44. The company has a quick ratio of 2.59, a current ratio of 2.93 and a debt-to-equity ratio of 5.46. The firm has a market cap of $4.70 billion, a P/E ratio of 86.90 and a beta of 2.07. The company has a 50-day moving average price of $15.10 and a two-hundred day moving average price of $12.90.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its quarterly earnings results on Monday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.15 by $0.04. Sotera Health had a return on equity of 47.26% and a net margin of 3.65%. The business had revenue of $277.00 million during the quarter, compared to analyst estimates of $266.45 million. During the same quarter in the prior year, the business posted $0.19 EPS. Sotera Health's revenue for the quarter was up 8.6% compared to the same quarter last year. Analysts anticipate that Sotera Health will post 0.64 earnings per share for the current year.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.